Reata links bardoxolone to improved walk test results by Nick Paul Taylor Thursday, March 22, 2018 The results come from a small, exploratory study Reata initiated after wrapping up a trial of the drug in its primary indication.
New discoveries in RA and skin cancer—News of Note by Arlene Weintraub Monday, March 5, 2018 The past week ushered in news about a toxin in scorpion venom that may relieve RA and a skin bacterium with anti-cancer powers.
Aradigm executives jump ship after FDA snub by Amirah Al Idrus Wednesday, February 14, 2018 Aradigm's CEO, chief medical officer and chief financial officer resigned.
Verona COPD drug beats Boehringer blockbuster in phase 2 by Nick Paul Taylor Thursday, September 7, 2017 Data from the phase 2a trial suggest Verona’s PDE3/PDE4 inhibitor may complement long-acting muscarinic antagonist bronchodilators such as Spiriva.
Genoa scores $62M Series A to take IPF drug into the clinic by Nick Paul Taylor Monday, May 15, 2017 Genoa Pharmaceuticals has raised $62 million to take its lead candidate into the clinic.
ALung nabs $36M for ‘respiratory dialysis’ device by Amirah Al Idrus Tuesday, April 11, 2017 ALung Technologies raised $36 million to trial its artificial lung technology for patients with respiratory failure.
FDA expands indication for BD's system to treat pleural effusion by Amirah Al Idrus Monday, January 23, 2017 The FDA cleared Becton Dickinson’s catheter system for treatment of non-malignant, recurrent pleural effusion, or the collection of fluid next to the lungs.
